NECTAR LIFESCIENCES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Nectar Lifesciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-4.99₹ -0.78
As on Nov 3, 2025, 4:01 PM IST
Nectar Lifesciences Price Performance
Today's LowToday's High
₹14.84₹15.52
₹14.84
52 Weeks' Low52 Weeks' High
₹13.25₹44.90
₹14.84
Open Price
₹15.50
Prev. Close
₹15.62
Volume
88,754
Over the last 5 years, the share price of Nectar Lifesciences has declined 3.95% CAGR. Over the past year, the corresponding return has been -62.06%.
Nectar Lifesciences’s current P/E of -1.85x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Nectar Lifesciences Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Nectar Lifesciences | -2.69 | 2.91 | -4.50 | -32.33 | -62.58 | -11.49 | -3.95 |
| Sun Pharmaceutical Industries | 0.95 | 2.97 | 3.79 | -7.19 | -5.84 | 18.13 | 29.41 |
| Divi's Laboratories | 5.50 | 16.49 | 4.51 | 10.65 | 15.11 | 20.95 | 17.36 |
| Torrent Pharmaceuticals | 1.14 | 2.65 | 0.16 | 10.21 | 13.14 | 28.97 | 23.26 |
| Cipla | -3.71 | -0.14 | -0.25 | -2.04 | -4.60 | 8.78 | 15.02 |
| Dr. Reddy's Laboratories | -7.29 | -4.17 | -2.36 | 2.04 | -5.64 | 9.63 | 4.26 |
| Mankind Pharma | 0.01 | -1.91 | -8.50 | -0.46 | -12.06 | 19.09 | 11.05 |
| Zydus Lifesciences | -2.06 | -1.36 | 2.19 | 9.93 | -2.34 | 31.30 | 19.05 |
| Lupin | 3.37 | 2.47 | 5.46 | -4.86 | -9.27 | 41.03 | 16.84 |
| Alkem Laboratories | 3.56 | 2.47 | 14.66 | 10.82 | -2.95 | 20.35 | 16.18 |
| Aurobindo Pharma | 5.07 | 5.39 | 5.90 | -7.04 | -17.91 | 28.09 | 8.74 |
| Abbott India | -2.40 | -3.17 | -14.56 | -5.50 | -1.28 | 13.95 | 13.40 |
| Glenmark Pharmaceuticals | 4.31 | -3.92 | -8.68 | 34.73 | 11.40 | 66.11 | 31.97 |
| Laurus Labs | 1.62 | 12.94 | 13.18 | 57.71 | 100.03 | 27.49 | 26.52 |
| Biocon | 3.31 | 8.86 | -1.16 | 12.55 | 21.54 | 11.88 | -1.32 |
| GlaxoSmithKline Pharmaceuticals | 1.03 | -1.86 | -6.30 | -7.22 | 2.76 | 24.87 | 13.76 |
| Anthem Biosciences | -1.42 | -7.99 | -6.64 | -3.74 | -3.74 | -1.26 | -0.76 |
| Ipca Laboratories | 2.03 | -0.90 | -9.17 | -5.71 | -17.50 | 12.27 | 2.64 |
| Gland Pharma | 3.51 | 1.53 | -0.60 | 38.80 | 22.33 | 3.29 | 1.58 |
| Ajanta Pharma | 6.35 | 4.37 | -3.80 | -2.04 | -15.31 | 24.26 | 19.30 |
Over the last one year, Nectar Lifesciences has declined 62.58% compared to peers like Sun Pharmaceutical Industries (-5.84%), Divi's Laboratories (15.11%), Torrent Pharmaceuticals (13.14%). From a 5 year perspective, Nectar Lifesciences has underperformed peers relative to Sun Pharmaceutical Industries (29.41%) and Divi's Laboratories (17.36%).
Nectar Lifesciences Financials
Nectar Lifesciences Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 15.46 | 15.21 |
| 10 | 14.54 | 14.9 |
| 20 | 14.26 | 14.66 |
| 50 | 14.77 | 15.13 |
| 100 | 16.86 | 17.12 |
| 200 | 22.23 | 21.15 |
Nectar Lifesciences Share Holding Pattern
In the latest quarter, Nectar Lifesciences saw a rise in promoter holding to 44.90%, while DII stake decreased to 0.10%, FII holding fell to 0.62%, and public shareholding moved down to 54.37% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Nectar Lifesciences Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 03, 2025, 8:59 PM IST | Nectar Lifesciences - Disclosure Received In Terms Of Regulation 7(3) Of SEBI(Prohibition Of Insider Trading) Regulation, 201 |
| Oct 30, 2025, 10:57 PM IST | Nectar Lifesciences - Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trad |
| Oct 27, 2025, 10:05 PM IST | Nectar Lifesciences - Announcement under Regulation 30 (LODR)-Change in Directorate |
| Oct 22, 2025, 8:50 PM IST | Nectar Lifesciences - Satisfaction Of Charge On Full Repayment Of Secured Debt, Along With The Accrued Interest To Consortium |
| Oct 17, 2025, 4:41 PM IST | Nectar Lifesciences - Update On Slump Sale |
About Nectar Lifesciences
Nectar Lifesciences Ltd. is a Public Limited Listed company incorporated on 27/06/1995 and has its registered office in the State of Punjab, India. Company's Corporate Identification Number(CIN) is L24232PB1995PLC016664 and registration number is 016664. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1669.97 Cr. and Equity Capital is Rs. 22.43 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressVillage Saidpura, Tehsil Derabassi, Mohali Punjab 140507
- Contact
Management
- Mr. Sanjiv GoyalChairman & Managing Director
- Dr. Surulichamy SenethilkumarDirector - R & D
- Dr. Indu Pal KaurIndependent Director
- Ms. Meena VermaNominee Director
- Dr. Rupinder TewariIndependent Director
- Dr. Kuldip Kumar BhasinIndependent Director
FAQs on Nectar Lifesciences Share Price
What is the share price of Nectar Lifesciences?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Nectar Lifesciences is ₹14.84 as on Nov 03, 2025.
What kind of stock is Nectar Lifesciences?
The Nectar Lifesciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Nectar Lifesciences?
The market cap of Nectar Lifesciences is ₹332.80 Cr as on Nov 03, 2025.
What are today's High and Low prices of Nectar Lifesciences?
Today’s highest and lowest price of Nectar Lifesciences are ₹15.52 and ₹14.84.
What are the 52 Week High and 52 Week Low of Nectar Lifesciences?
The 52-week high/low is the highest and lowest price at which Nectar Lifesciences stock has traded in the past 52-week or nearly a year. The 52-week high of Nectar Lifesciences is ₹44.90 and 52-week low of Nectar Lifesciences is ₹13.25 as on Nov 03, 2025.
How has the Nectar Lifesciences performed historically in terms of returns?
The Nectar Lifesciences has shown returns of -4.99% over the past day, 4.43% for the past month, -8.96% over 3 months, -62.06% over 1 year, -11.49% across 3 years, and -3.95% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Nectar Lifesciences?
P/E ratio of and PB ratio of Nectar Lifesciences are -1.85 and 0.35 on Nov 03, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse